LEKHA PARAMBEN: Open Payments
NPI 1861853517 · MORTON GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 71 payments from 29 companies in 2025. Trend: 2023 $1,182 · 2024 $1,368 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $185 |
| Kowa Pharmaceuticals America, Inc. | 7 | $141 |
| Ardelyx, Inc. | 4 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Alpha Cognition USA, Inc. | 2 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| GlaxoSmithKline, LLC. | 3 | $82 |
| SCILEX PHARMACEUTICALS INC. | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
Products named: ZORYVE, IBSRELA, Ozempic, CAPLYTA, Zunveyl, Kerendia, ZTLido, REXULTI.
Industry payments across IL — which companies pay providers there.
